Bray Capital Advisors Bristol Myers Squibb CO Transaction History

Bray Capital Advisors

$381 Million
Q1 2024

A detailed history of Bray Capital Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bray Capital Advisors holds 5,399 shares of BMY stock, worth $222,006. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,399

Previous 5,345 1.01%

Holding current value

$222,006

Previous $274,000 6.57%

% of portfolio

0.08%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $2,590 - $2,937	54 Added 1.01%	5,399 $292,000
Q4 2023 Jan 29, 2024	BUY	$48.48 - $57.85 $2,375 - $2,834	49 Added 0.93%	5,345 $274,000
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $2,373 - $2,653	41 Added 0.78%	5,296 $307,000
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $2,293 - $2,546	36 Added 0.69%	5,255 $336,000
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $2,168 - $2,459	33 Added 0.64%	5,219 $361,000

Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $2,054 - $2,432	30 Added 0.58%	5,186 $0
Q3 2022 Nov 21, 2022	BUY	$0.13 - $76.84 $3 - $2,305	30 Added 0.59%	5,156 $367,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $2,251 - $2,479	31 Added 0.61%	5,126 $395,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $19,981 - $23,959	-325 Reduced 6.0%	5,095 $372,000
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $847,300 - $987,753	-15,799 Reduced 74.46%	5,420 $338,000
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $81,536 - $95,509	-1,378 Reduced 6.1%	21,219 $1.26 Million
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $46,370 - $50,497	-749 Reduced 3.21%	22,597 $1.51 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $1,839 - $2,068	31 Added 0.13%	23,346 $1.47 Million
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $1,674 - $1,897	29 Added 0.12%	23,315 $1.45 Million
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $11,198 - $12,409	195 Added 0.84%	23,286 $1.4 Million
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $260,943 - $305,068	4,760 Added 25.97%	23,091 $1.36 Million
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $81,060 - $117,800	1,747 Added 10.53%	18,331 $1.02 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $94,089 - $122,731	1,912 Added 13.03%	16,584 $1.07 Million
Q3 2019 Oct 29, 2019	SELL	$42.77 - $50.71 $20,914 - $24,797	-489 Reduced 3.23%	14,672 $744,000
Q2 2019 Jul 29, 2019	BUY	$44.62 - $49.34 $181,603 - $200,813	4,070 Added 36.7%	15,161 $688,000
Q1 2019 Apr 30, 2019	BUY	$45.12 - $53.8 $1,037 - $1,237	23 Added 0.21%	11,091 $529,000
Q4 2018 Feb 15, 2019	BUY	$48.76 - $63.23 $56,464 - $73,220	1,158 Added 11.69%	11,068 $575,000
Q3 2018 Oct 31, 2018	BUY	$55.19 - $62.25 $1,103 - $1,245	20 Added 0.2%	9,910 $615,000
Q2 2018 Jul 31, 2018	BUY	$50.53 - $62.98 $1,162 - $1,448	23 Added 0.23%	9,890 $547,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $76,757 - $88,363	1,281 Added 14.92%	9,867 $624,000
Q4 2017 Feb 02, 2018	BUY	$59.94 - $65.35 $92,187 - $100,508	1,538 Added 21.82%	8,586 $526,000
Q3 2017 Nov 01, 2017	BUY	$55.23 - $63.74 $389,261 - $449,239	7,048	7,048 $449,000

Others Institutions Holding BMY

# of Institutions

2,552

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.

Account

Bray Capital Advisors Bristol Myers Squibb CO Transaction History